Krka Reports 21% Surge in Profit
Novo Mesto, 25 January - Pharma group Krka said on Thursday that the profits of its core pharmaceuticals unit rose by 21% in 2006 to EUR 121m, in line with expectations.
The rest of this news item is available to subscribers.
The news item consists of 1.132 characters (without spaces) or 244 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.